Lapatinib , used in the form of lapatinib ditosylate, (Tykerb/Tyverb, GSK) is an orally active drug for breast cancer and other solid tumours. 
TYKERB ® (lapatinib) is designed to inhibit HER2 receptors. HER2 is a type of protein found on normal cells as well as breast cancer cells; In women with HER2 ...
Learn about the prescription medication Tykerb (Lapatinib), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling.
FDA Approval for Lapatinib Ditosylate. Use in Cancer. Lapatinib ditosylate is approved to be used with other drugs to treat: Breast cancer that is advanced or has ...
(la-PA-ti-nib) Trade name: TYKERB® (la-PA-ti-nib) Trade name: TYKERB® Chemocare.com uses generic names in all descriptions of drugs. TYKERB is the trade name for ...
Easy to read patient leaflet for lapatinib. Includes indications, proper use, special instructions, precautions, and possible side effects.
Lapatinib is a cancer medication. Lapatinib is used together with another medicine called capecitabine (Xeloda) or letrozole (Femara) to treat a certain type of ...
Find out about lapatinib (also known as Tyverb®), which is mainly being used to treat women with advanced breast cancer
Lapatinib may cause liver damage which can be severe or life-threatening. Liver damage can occur as soon as several days or as late as several months after ...
Lapatinib side effects. To prevent problematic interactions between lapatinib and other drugs, be sure to tell your doctor if you are allergic to any medications, and ...